Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 5.101\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a. CCN(CC)S(=O)(=O)c1cccc(C(=O)N2CCCCC2)c1
b. O=C(c1ccc(Cl)cc1[N+](=O)[O-])N(Cc1ccccc1)Cc1ccccc1
c. COC(=O)C1=C(O)/C(=C\c2ccc(CNS(=O)(=O)c3ccc(Cl)cc3)o2)N=C1C
d. CCN1CCN(c2ncnc3c2nnn3Cc2ccccc2)CC1
e. CCN(CC)C(=O)C1CCCN(c2ccc([N+](=O)[O-])cc2/C=N/NC(=O)c2cccc(O)c2)C1
Answer: d. CCN1CCN(c2ncnc3c2nnn3Cc2ccccc2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN1CCN(c2ncnc3c2nnn3Cc2ccccc2)CC1
CCN1CCN(c2ncnc3c2nnn3Cc2ccccc2)CC1
[C][C][N][C][C][N][Branch2][Ring1][#Branch1][C][=N][C][=N][C][=C][Ring1][=Branch1][N][=N][N][Ring1][Branch1][C][C][=C][C][=C][C][=C][Ring1][=Branch1][C][C][Ring2][Ring1][=Branch1]
3-benzyl-7-(4-ethylpiperazin-1-yl)triazolo[4,5-d]pyrimidine